澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

AROVELLA THERAPEUTICS LTD

0.087

-0.002-2.25%

成交量：22.45万

成交额：1.96万

市值：1.05亿

市盈率：-12.82

高：0.088

开：0.087

低：0.087

收：0.089

52周最高：0.195

52周最低：0.068

股本：12.01亿

流通股本：8.96亿

量比：0.75

换手率：0.03%

股息：- -

股息率：- -

每股收益(TTM):-0.007

每股收益(LYR):-0.007

净资产收益率：-52.05%

总资产收益率：-32.25%

市净率：5.52

市盈率(LYR):-12.71

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

Arovella Therapeutics向美国FDA提交Ala-101首次人体一期试验新药研究申请

Arovella Therapeutics Ltd的CAR-iNKT细胞平台美国专利申请获准授权

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/ALA.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ALA.AU\",,,,,undefined,":{"symbol":"ALA.AU","market":"AU","secType":"STK","nameCN":"AROVELLA THERAPEUTICS LTD","latestPrice":0.087,"timestamp":1771891232387,"preClose":0.089,"halted":0,"volume":224499,"delay":0,"changeRate":-0.02247191011235957,"nameEN":"AROVELLA THERAPEUTICS LTD","floatShares":895858885,"shares":1201183672,"eps":-0.006785,"marketStatus":"交易中","change":-0.002,"latestTime":"02-24 11:33:18 AEDT","open":0.087,"high":0.088,"low":0.087,"amount":19612,"amplitude":0.011236,"askPrice":0.088,"askSize":4851,"bidPrice":0.087,"bidSize":71101,"shortable":3,"etf":0,"ttmEps":-0.006785,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1771909200000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.089,"openAndCloseTimeList":[[1771887600000,1771909200000]],"volumeRatio":0.74722,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ALA.AU\",,,,,undefined,":{"symbol":"ALA.AU","floatShares":895858885,"roa":"-32.25%","roe":"-52.05%","lyrEps":-0.006843,"volumeRatio":0.74722,"shares":1201183672,"dividePrice":0,"high":0.088,"amplitude":0.011236,"preClose":0.089,"low":0.087,"week52Low":0.068,"pbRate":"5.52","psRate":"32.56","week52High":0.195,"institutionHeld":0,"latestPrice":0.087,"committee":0.872261,"eps":-0.006785,"divideRate":0,"volume":224499,"delay":0,"ttmEps":-0.006785,"open":0.087,"prevYearClose":0.093,"prevWeekClose":0.09,"prevMonthClose":0.086,"prevQuarterClose":0.093,"fiveDayClose":0.087,"twentyDayClose":0.085,"sixtyDayClose":0.082},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALA.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALA.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1138242283","title":"Arovella Therapeutics向美国FDA提交Ala-101首次人体一期试验新药研究申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1138242283","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138242283?lang=zh_cn&edition=fundamental","pubTime":"2025-12-30 09:19","pubTimestamp":1767057555,"startTime":"0","endTime":"0","summary":"Arovella Therapeutics Ltd宣布已正式向美国食品药品监督管理局提交Ala-101的新药临床试验申请，该项申请旨在启动该药物的首次人体一期临床试验。这一重要进展标志着公司创新疗法开发迈入新的阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","ALA.AU"],"gpt_icon":0},{"id":"1121490968","title":"Arovella Therapeutics Ltd的CAR-iNKT细胞平台美国专利申请获准授权","url":"https://stock-news.laohu8.com/highlight/detail?id=1121490968","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121490968?lang=zh_cn&edition=fundamental","pubTime":"2025-08-28 06:29","pubTimestamp":1756333754,"startTime":"0","endTime":"0","summary":"Arovella Therapeutics Ltd的CAR-iNKT细胞平台美国专利申请将获得授权批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALA.AU","BK7096"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ALA.AU\",params:#limit:6,delay:true,,,undefined,":[]}}